Clinical and Experimental Nephrology

, Volume 2, Issue 2, pp 142–150 | Cite as

Clinical characterization of acute renal failure in multiple organ dysfunction syndrome

  • Akinori Soejima
  • Nobuyuki Miyake
  • Naoki Matsuzawa
  • Masayuki Waku
  • Kazuhito Fukuoka
  • Yasushi Kamiya
  • Kiyoshi Kitamoto
  • Toshihiko Nagasawa
Original Article Clinical Investigations

Abstract

Background

Acute renal failure frequently occurs as a complication of multiple organ dysfunction syndrome (MODS). Various forms of therapy for MODS, including endotoxin absorption and anticytokine therapy, have been attempted.

Methods

We retrospectively studied the pathophysiologic characteristics of acute renal failure in 152 MODS patients examined in our department over the past 5 years. The diagnosis of MODS was based on the criteria of the Japanese Association for Critical Care Medicine. The diagnosis of systemic inflammatory response syndrome (SIRS) and sepsis was conducted in accordance with the definition proposed at the 1992 Consensus Conference of the American College of Chest Physicians/ Society of Critical Care Medicine.

Results

Acute renal failure occurred as a complication of secondary MODS with a high frequency of 76.3% (116/152 patients). Significant associations have been found between the respective frequencies of acute renal failure and disseminated intravascular coagulation occurring as complications of SIRS. An increase in the number of cases undergoing continuous hemodiafiltration was noted, in an attempt to improve the survival rate of MODS complicated with acute renal failure.

Conclusion

Acute renal failure seen in secondary MODS is thought to be derived from a pathogenesis differing from that of conventional intrinsic acute renal failure, such as ischemic and nephrotoxic forms. Acute renal failure associated with secondary MODS appears to be a disease entity that arises as a sequela of SIRS, similar to disseminated intravascular coagulation.

Key words

acute renal failure multiple organ dysfunction syndrome systemic inflammatory response syndrome bacterial translocation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Druml W. Prognosis of acute renal failure 1975–1995. Nephron 1996;73:8–15.PubMedGoogle Scholar
  2. 2.
    Liano F, Pascual J, Madrid Acute Renal Failure Study Group Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996;50:811–818.PubMedGoogle Scholar
  3. 3.
    Liano F, Gallego A, Pascual J, Garcia-Martin F, Teruel JL, Marcen R, Orofino L, Orte L, Rivera M, Gallego N, Quereda C, Ortuno J. Prognosis of acute tubular necrosis: an extended prospectively contrasted study. Nephron 1993;63:21–31.PubMedGoogle Scholar
  4. 4.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644–1655.PubMedGoogle Scholar
  5. 5.
    Japanese Association for Critical Care Medicine. Diagnostic criteria for multiple organ failure. J Jpn Assoc Crit Care Med 1990;4:134–135.Google Scholar
  6. 6.
    Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990;(suppl 12):S184-S190.CrossRefGoogle Scholar
  7. 7.
    Wardle EN. Acute renal failure and multiorgan failure. Nephron 1994;66:380–385.PubMedCrossRefGoogle Scholar
  8. 8.
    Shimaoka K. Disseminated intravascular coagulation (DIC). J Jpn Soc of Intern Med 1997;86:915–922.Google Scholar
  9. 9.
    Johnson JP, Rokaw MD. Sepsis or ischemia in experimental acute renal failure: what have we learned? New Horiz 1995;3:608–614.PubMedGoogle Scholar
  10. 10.
    Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 1993;43:1160–1178.PubMedGoogle Scholar
  11. 11.
    Ueda N, Walker PD, Shab SV. Oxidant stress in acute renal failure. In: Goligorsky MS (ed). Acute renal failure. New York: Churchill Livingstone, 1995:45–74.Google Scholar
  12. 12.
    Iino S. ALP, ALP isoenzyme. In: Nakai T (ed) Interpretation of clinical laboratory tests. Tokyo: Chugai Igakusha, 1996;184–185.Google Scholar
  13. 13.
    Biesenbach G, Zazgornik J, Kaiser W, Grafinger P, Stuby U, Necek S. Improvement in prognosis of patients with acute renal failure over a period of 15 years: an analysis of 710 cases in a dialysis center. Am J Nephrol 1992;12:319–315.PubMedGoogle Scholar
  14. 14.
    Matsuda K, Oda S, Hirasawa H. Continuous hemodiafiltration for the management of SIRS. Jpn J Acute Med 1996;20:1105–1109.Google Scholar
  15. 15.
    Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563–1570.PubMedGoogle Scholar

Copyright information

© CEN/CLJ 1998

Authors and Affiliations

  • Akinori Soejima
    • 1
  • Nobuyuki Miyake
    • 1
  • Naoki Matsuzawa
    • 1
  • Masayuki Waku
    • 1
  • Kazuhito Fukuoka
    • 1
  • Yasushi Kamiya
    • 1
  • Kiyoshi Kitamoto
    • 1
  • Toshihiko Nagasawa
    • 1
  1. 1.Department of Internal MedicineKyorin University School of MedicineMitaka, TokyoJapan

Personalised recommendations